You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 28, 2024

RIZAFILM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Rizafilm patents expire, and when can generic versions of Rizafilm launch?

Rizafilm is a drug marketed by Gensco and is included in one NDA. There is one patent protecting this drug.

This drug has twenty patent family members in sixteen countries.

The generic ingredient in RIZAFILM is rizatriptan benzoate. There are twenty-two drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the rizatriptan benzoate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Rizafilm

A generic version of RIZAFILM was approved as rizatriptan benzoate by AUROBINDO PHARMA LTD on December 31st, 2012.

  Try a Trial

Summary for RIZAFILM
International Patents:20
US Patents:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
What excipients (inactive ingredients) are in RIZAFILM?RIZAFILM excipients list
DailyMed Link:RIZAFILM at DailyMed
Drug patent expirations by year for RIZAFILM

US Patents and Regulatory Information for RIZAFILM

RIZAFILM is protected by one US patents.

Patents protecting RIZAFILM


Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gensco RIZAFILM rizatriptan benzoate FILM;ORAL 205394-001 Apr 14, 2023 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for RIZAFILM

See the table below for patents covering RIZAFILM around the world.

Country Patent Number Title Estimated Expiration
Chile 2016000160 Pelicula oral que comprende hidroxipropilcelulosa sola o combinada con polivinilpirrolidona, al menos un copolímero de vinilpirrolidona, dioxido de titanio, en donde la relación del copolímero de vinilpirrolidona con el dioxido de titanio es de 3 es a 1 a 5 es a 1, y rizatriptán, zolmitriptán, alprazolam, diazepam o lorazepam, como principio activo. ⤷  Try a Trial
Japan 2016527262 界面活性剤および多価アルコールを有さず直ちに湿潤可能な経口フィルム剤形 ⤷  Try a Trial
Russian Federation 2016106907 МГНОВЕННО СМАЧИВАЮЩАЯСЯ ПЕРОРАЛЬНАЯ ПЛЕНОЧНАЯ ЛЕКАРСТВЕННАЯ ФОРМА БЕЗ ПОВЕРХНОСТНО-АКТИВНОГО ВЕЩЕСТВА ИЛИ ПОЛИСПИРТА ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for RIZAFILM

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0497512 SPC/GB98/035 United Kingdom ⤷  Try a Trial PRODUCT NAME: RIZATRIPTAN, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, ESPECIALLY RIZATRIPTAN BENZOATE; REGISTERED: NL 21815 19980211; NL 21816 19980211; NL 21817 19980211; NL 21818 19980211; UK 00025/0369 19980624; UK 00025/0370 19980624; UK 00025/0371 19980624; UK 00025/0372 19980624
0497512 99C0011 Belgium ⤷  Try a Trial PRODUCT NAME: RIZATRIPTAN BENZOAS EQ. RIZATRIPTAN; REGISTRATION NO/DATE: 922 IS 181 F 3 19981130; FIRST REGISTRATION: NL RVG 21815 19980211
0497512 C980019 Netherlands ⤷  Try a Trial PRODUCT NAME: RIZATRIPTAN, DESGEWENST IN DE VORM VAN EEN ZOUT, IN HET BIJZOND ER RIZATRIPTAN-BENZOAAT; REGISTRATION NO/DATE: RVG 21815 - RVG 21818 19980211
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.